Creutzfeldt-Jakob disease and advanced therapy medicinal products - Scientific guideline

HumanAdvanced therapiesScientific guidelines

This document considers the risk of transmitting Creutzfeldt-Jakob disease (CJD) or variant CJD agents via the advanced therapy medicinal products.

Keywords: Creutzfeldt-Jakob disease, gene therapy, cell therapy and tissue engineering medicinal products, donor selection criteria, tissue and blood donation

Current effective version

Document history - First version (current)

Share this page